ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,193Medicare Part D Prescriptions Filled, Including Refills

Rank: 154 out of 2888

$891K Total Retail Price of All Prescriptions

Rank: 281 out of 2888

550 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 550 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

43% of this provider’s 550 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 12,571 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,025 606 S3 1 4
LISINOPRIL 745 557 2 3
SIMVASTATIN 664 467 3 2
LEVOTHYROXINE SODIUM 500 402 4 1
OMEPRAZOLE 431 318 5 7
FUROSEMIDE 344 303 6 6
METOPROLOL TARTRATE 335 297 7 10
AMLODIPINE BESYLATE 333 289 8 5
METFORMIN HCL 325 213 9 8
GABAPENTIN 321 226 10 13
WARFARIN SODIUM 320 281 11 22
PANTOPRAZOLE SODIUM 276 187 12 33
LOVASTATIN 273 259 13 41
POTASSIUM CHLORIDE 250 205 14 14
CARVEDILOL 238 188 15 21
ATORVASTATIN CALCIUM 227 173 16 9
MELOXICAM 217 143 17 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 208 115 18 28
ZOLPIDEM TARTRATE 205 158 19 17
NEXIUM 190 115 20 19
METOPROLOL SUCCINATE 185 168 21 11
CITALOPRAM HBR 174 146 22 24
LOSARTAN POTASSIUM 167 124 23 18
HYDROCHLOROTHIAZIDE 163 150 24 15
TRILIPIX 158 74 25 160
CYCLOBENZAPRINE HCL 146 78 R 26 68
FLUTICASONE PROPIONATE 141 96 27 32
TRAZODONE HCL 139 108 28 43
CRESTOR 125 81 29 20
SERTRALINE HCL 125 77 29 27
TRAMADOL HCL 122 90 31 16
GLIMEPIRIDE 121 84 32 36
CELEBREX 116 71 33 89
ALENDRONATE SODIUM 116 101 33 23
FLUOXETINE HCL 112 67 35 83
CLOPIDOGREL 110 97 36 30
MORPHINE SULFATE ER 109 37 S2 37 229
AZITHROMYCIN 109 86 37 38
FENOFIBRATE 106 67 39 65
DICLOFENAC SODIUM 97 40 40 141
DIGOXIN 96 96 41 55
CLONIDINE HCL 96 90 41 39
BACLOFEN 95 62 43 121
VERAPAMIL ER 85 63 44 104
CEFUROXIME 85 58 44 130
FENTANYL 83 55 S2 46 126
LABETALOL HCL 81 56 47 180
ATENOLOL 81 59 47 25
SPIRIVA 80 63 49 79
PROAIR HFA 80 63 49 71
CIPROFLOXACIN HCL 79 63 51 47
METHOCARBAMOL 78 39 R 52 176
PAROXETINE HCL 77 45 53 84
ETODOLAC 77 55 53 170
CYMBALTA 77 53 53 44
ENALAPRIL MALEATE 75 60 56 49
DONEPEZIL HCL 74 74 57 26
GLYBURIDE 74 67 R 57 58
AMOXICILLIN 74 46 57 117
PROPRANOLOL HCL 73 50 60 164
PLAVIX 72 70 61 40
PREDNISONE 72 37 61 42
TAMSULOSIN HCL 71 68 63 29
ISOSORBIDE MONONITRATE ER 71 53 63 51
LANSOPRAZOLE 71 14 63 213
BENAZEPRIL HCL 70 70 66 77
LEVOFLOXACIN 70 54 66 57
DILTIAZEM 24HR CD 63 58 68 146
HYDROXYZINE HCL 62 40 R 69 174
AMITRIPTYLINE HCL 59 51 R 70 74
ESCITALOPRAM OXALATE 59 42 70 62
SYNTHROID 58 52 72 52
PRAVASTATIN SODIUM 58 49 72 12
MIRTAZAPINE 58 36 72 54
ADVAIR DISKUS 57 41 75 60
VENTOLIN HFA 56 26 76 173
BUSPIRONE HCL 56 39 76 148
JANUMET 56 36 76 131
PREMARIN 56 30 R 76 129
INSULIN SYRINGE 55 38 80 86
GLIPIZIDE 52 40 81 50
GEMFIBROZIL 50 31 82 98
DEXILANT 50 38 82 186
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.